Pierpaolo Pellicori

Sep 5, 2024 | nature.com | Fang-Fei Wei |Pierpaolo Pellicori |Joao Ferreira |Arantxa González |De-Wei An |Chen Liu | +10 more

AbstractNone of the spironolactone trials in heart failure (HF) assessed the blood pressure (BP) responses to exercise, while conflicting results were reported for exercise capacity. In the HOMAGE trial, 527 patients at increased HF risk were randomized to usual treatment with or without spironolactone (25–50 mg/day). The current substudy included 113 controls and 114 patients assigned spironolactone, who all completed the incremental shuttle walk test at baseline and months 1 and 9.

Jul 17, 2024 | onlinelibrary.wiley.com | Pierpaolo Pellicori |Joe Cuthbert |Andrew Clark |John Cleland

Invited Editorial Managing water and salt balance in heart failure: Is there anything else to consider other than diet and diuretics? Reduced congestion and improved response to a fluid/sodium challenge in chronic heart failure patients after initiation of sacubitril/valsartan: The NATRIUM-HF study Alexandre Mebazaa, Beth A. Davison, Jan Biegus, Christopher Edwards, Gillian Murtagh, Christos Varounis, Hamlet Hayrapetyan, Hamayak Sisakian, Victor R.

Feb 20, 2024 | onlinelibrary.wiley.com | Pierpaolo Pellicori |G. Michael Felker |John G.F. Cleland

Letter to the Editor Reply to ‘Vasodilators in congestive heart failure: The perfect weapon aiming just off the target?’ Pierpaolo Pellicori,  Corresponding Author Pierpaolo Pellicori School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK Corresponding author. Email: [email protected] for more papers by this authorG. Michael Felker,  G.

Jul 3, 2023 | onlinelibrary.wiley.com | Fraser Graham |Pierpaolo Pellicori |Gabriele Masini |Surgical Specialties

Discussion We have identified patients with CHF and a low SIC (≤13 μmol/L), low haemoglobin and a high mortality who do not fulfil the current guideline definition of iron deficiency and have been excluded from landmark trials of iron repletion.6, 26 We have also identified patients with a normal SIC who do fulfil the current guideline definition of iron deficiency, who have a relatively low prevalence of anaemia and relatively good prognosis who may not have iron deficiency; their inclusion...

May 22, 2023 | onlinelibrary.wiley.com | Pierpaolo Pellicori |Pasquale Dolce |Antonio Iaconelli |Matteo Busti

Research Article This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi: 10.1002/ejhf.2911. Abstract Background and aims Coronary artery disease (CAD) is a common cause of heart failure (HF).